Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kian Chuan Sia

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Journal of Gene Medicine|December 29, 2018
Development of a liver-specific Tet-off AAV8 vector for improved safety of insulin gene therapy for diabetesShu Uin Gan, Zhenying Fu, Kian Chuan Sia, et al.
Cells|November 18, 2020
Modification of a Constitutive to Glucose-Responsive Liver-Specific Promoter Resulted in Increased Efficacy of Adeno-Associated Virus Serotype 8-Insulin Gene Therapy of Diabetic MiceKian Chuan Sia, Zhen Ying Fu, Roy Y Calne, et al.
International Journal of Molecular Sciences|August 10, 2024
Efficient AAV9 Purification Using a Single-Step AAV9 Magnetic Affinity Beads IsolationKian Chuan Sia, Zhen Ying Fu, Siti Humairah Mohd Rodhi, et al.
The Journal of Gene Medicine|October 22, 2010
Hybrid herpes simplex virus/Epstein-Barr virus amplicon viral vectors confer enhanced transgene expression in primary human tumors and human bone marrow-derived mesenchymal stem cellsKian Chuan Sia, Wei Kin Chong, Ivy A W Ho, et al.
Journal of Virological Methods|November 1, 2006
Optimal purification method for Herpes-based viral vectors that confers minimal cytotoxicity for systemic route of vector administrationKian Chuan Sia, Grace Y Wang, Ivy A W Ho, et al.
Gene Therapy|February 2, 2022
First use of gene therapy to treat growth hormone resistant dwarfism in a mouse modelKian Chuan Sia, Shu Uin Gan, Siti Humairah Mohd Rodhi, et al.
Current Gene Therapy|January 23, 2016
Correction of Murine Diabetic Hyperglycaemia With A Single Systemic Administration of An AAV2/8 Vector Containing A Novel Codon Optimized Human Insulin GeneShu Uin Gan, Maria Notaridou, Zhen Ying Fu, et al.
Molecular Cancer Therapeutics|May 31, 2013
Preclinical evaluation of transcriptional targeting strategy for human hepatocellular carcinoma in an orthotopic xenograft mouse modelKian Chuan Sia, Hung Huynh, Alexander Yaw Fui Chung, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 10, 2017
An Efficient and Safe Herpes Simplex Virus Type 1 Amplicon Vector for Transcriptionally Targeted Therapy of Human Hepatocellular CarcinomasPaula Yp Lam, Kian Chuan Sia, Jenn H Khong, et al.
Frontiers in Endocrinology|June 15, 2026
GH-resistant (Laron) mice: gene therapy with a liver-specific GH receptor causes unbalanced upregulation of female-biased and growth-related genesJoshua K Tay, Kian Chuan Sia, Siti Humairah Mohd Rodhi, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Journal of Gene Medicine|December 29, 2018
Development of a liver-specific Tet-off AAV8 vector for improved safety of insulin gene therapy for diabetesShu Uin Gan, Zhenying Fu, Kian Chuan Sia, et al.
Cells|November 18, 2020
Modification of a Constitutive to Glucose-Responsive Liver-Specific Promoter Resulted in Increased Efficacy of Adeno-Associated Virus Serotype 8-Insulin Gene Therapy of Diabetic MiceKian Chuan Sia, Zhen Ying Fu, Roy Y Calne, et al.
International Journal of Molecular Sciences|August 10, 2024
Efficient AAV9 Purification Using a Single-Step AAV9 Magnetic Affinity Beads IsolationKian Chuan Sia, Zhen Ying Fu, Siti Humairah Mohd Rodhi, et al.
The Journal of Gene Medicine|October 22, 2010
Hybrid herpes simplex virus/Epstein-Barr virus amplicon viral vectors confer enhanced transgene expression in primary human tumors and human bone marrow-derived mesenchymal stem cellsKian Chuan Sia, Wei Kin Chong, Ivy A W Ho, et al.
Journal of Virological Methods|November 1, 2006
Optimal purification method for Herpes-based viral vectors that confers minimal cytotoxicity for systemic route of vector administrationKian Chuan Sia, Grace Y Wang, Ivy A W Ho, et al.
Gene Therapy|February 2, 2022
First use of gene therapy to treat growth hormone resistant dwarfism in a mouse modelKian Chuan Sia, Shu Uin Gan, Siti Humairah Mohd Rodhi, et al.
Current Gene Therapy|January 23, 2016
Correction of Murine Diabetic Hyperglycaemia With A Single Systemic Administration of An AAV2/8 Vector Containing A Novel Codon Optimized Human Insulin GeneShu Uin Gan, Maria Notaridou, Zhen Ying Fu, et al.
Molecular Cancer Therapeutics|May 31, 2013
Preclinical evaluation of transcriptional targeting strategy for human hepatocellular carcinoma in an orthotopic xenograft mouse modelKian Chuan Sia, Hung Huynh, Alexander Yaw Fui Chung, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 10, 2017
An Efficient and Safe Herpes Simplex Virus Type 1 Amplicon Vector for Transcriptionally Targeted Therapy of Human Hepatocellular CarcinomasPaula Yp Lam, Kian Chuan Sia, Jenn H Khong, et al.
Frontiers in Endocrinology|June 15, 2026
GH-resistant (Laron) mice: gene therapy with a liver-specific GH receptor causes unbalanced upregulation of female-biased and growth-related genesJoshua K Tay, Kian Chuan Sia, Siti Humairah Mohd Rodhi, et al.
Pageof 2